Virtual Library

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    International Society of Nurses in Cancer Care (ISNCC) & BMS Foundation Collaborative Workshop (Sign up Required)

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 15
    • Coordinates: 12/04/2016, 08:00 - 12:00, Schubert 5
    • +

      Participants Registration and Check in Opens

      08:00 - 08:30

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Opening remarks

      08:30 - 08:46

      • Abstract

      Abstract not provided

    • +

      The power of advocacy to ignite change & reverse stigma

      08:46 - 08:57

      • Abstract

      Abstract not provided

    • +

      Are we ready? Educating providers and increasing access to lung cancer screening

      08:57 - 09:08

      • Abstract

      Abstract not provided

    • +

      The elephant in the room: smoking cessation intervention from prevention to palliative care

      09:08 - 09:19

      • Abstract

      Abstract not provided

    • +

      The system is too complex! Navigating the lung cancer screening waters from early detect ion through to clinical resolution

      09:19 - 09:30

      • Abstract

      Abstract not provided

    • +

      Meeting people in their community: screening education and outreach to hard to reach populations through churches and other community engagement strategies

      09:30 - 09:41

      • Abstract

      Abstract not provided

    • +

      Building Survivorship Services and Survivorship Care Plans

      09:41 - 09:52

      • Abstract

      Abstract not provided

    • +

      Dignity and comfort: Providing quality palliative care

      09:52 - 10:02

      • Abstract

      Abstract not provided

    • +

      Networking break

      10:02 - 10:20

      • Abstract

      Abstract not provided

    • +

      Instruction on small groups work: Based on pre -set questions, participants will organize themselves into 4 tables to offer suggestions on steps forward, based on lessons learned from projects presented and taking into account resource limitations.

      10:20 - 10:30

      • Abstract

      Abstract not provided

    • +

      Small group discussion on topics presented with recommendations for implemen tation in “real life” settings on the pre -assigned topics

      10:30 - 11:20

      • Abstract

      Abstract not provided

    • +

      Group s report back

      11:20 - 11:35

      • Abstract

      Abstract not provided

    • +

      Synthesis and recommendations

      11:35 - 11:50

      • Abstract

      Abstract not provided

    • +

      Closing remarks

      11:50 - 11:55

      • Abstract

      Abstract not provided

  • +

    JCES01 - Joint IASLC - Chinese Society for Clinical Oncology - Chinese Alliance Against Lung Cancer Session

    • Type: Joint Chinese / English Session
    • Track:
    • Presentations: 28
    • +

      JCES01.01 - Breakfast and Informal Networking

      08:00 - 08:20

      • Abstract

      Abstract not provided

    • +

      JCES01.02 - Welcome and Introduction

      08:20 - 08:30  |  Author(s): F.R. Hirsch, Y.-. Wu, C. Bai

      • Abstract
      • Presentation

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Discovering the East: Precision Medicine in China

      08:30 - 08:30

      • Abstract

      Abstract not provided

    • +

      JCES01.04 - Liquid Biopsy in Monitoring Dynamic Changes of Driver Genes in Advanced NSCLC

      08:30 - 08:50  |  Author(s): Q. Zhou

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.05 - New Clinical Trials on Gene Alteration in China

      08:50 - 09:10  |  Author(s): S. Lu

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Precision Medicine – Perspectives from the West

      09:10 - 09:10

      • Abstract

      Abstract not provided

    • +

      JCES01.06 - European Perspective Phase I Strategy

      09:10 - 09:30  |  Author(s): C. Rolfo

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.07 - North American Perspective

      09:30 - 09:50  |  Author(s): P.A. Bunn, Jr.

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.08 - Break

      09:50 - 10:10

      • Abstract

      Abstract not provided

    • +

      Abstract Presentations from China Related to Precision Medicine

      10:10 - 10:10

      • Abstract

      Abstract not provided

    • +

      JCES01.09 - A Comparison of ddPCR and ARMS for Detecting EGFR T790M Status from Advanced NSCLC Patients with Acquired EGFR-TKI Resistance

      10:10 - 10:20  |  Author(s): W. Wang, Z. Song, Y. Zhang, Y. Jin

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.10 - Serial Quantitative Assessment of Plasma Circulating Tumor DNA by Digital NGS in Patients with Lung Cancer

      10:20 - 10:30  |  Author(s): Y. Zhao, J. Gong, W. Ma, K.C. Banks, H. Wen, E.H. Moore, R.B. Lanman, T. Li

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.11 - Altered Expression of Programmed Death-Ligand 1 after Neo-Adjuvant Chemotherapy in Patients with Lung Squamous Cell Carcinoma

      10:30 - 10:40  |  Author(s): Z. Song, Y. Zhang, X. Yu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.12 - Discussant Oral Abstracts

      10:40 - 10:55  |  Author(s): J.C. Yang

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.13 - Discussant Posters

      10:55 - 11:10  |  Author(s): X. Zhang

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.14 - Mutational Profiling of Non-Small-Cell Lung Cancer Patients Resistant to First-Generation EGFR Tyrosine Kinase Inhibitors Using next Generation Sequencing

      11:10 - 11:10  |  Author(s): Y. Jin, X. Yu, X. Shi, Y. Zhang, G. Lou

      • Abstract

      Loading...

    • +

      JCES01.15 - Analysis of Genomic Alterations and Heterogeneity in Pulmonary Adenoid Cystic Carcinoma by Next-Generation Sequencing

      11:10 - 11:10  |  Author(s): M. Li, B. Zhao, P. Deng, L. Cao, H. Yang, Q. Gu, C. Hu

      • Abstract

      Loading...

    • +

      JCES01.16 - A MET Inhibitor in the Treatment of Metastatic Non Small Cell Lung Cancer with MET Amplification

      11:10 - 11:10  |  Author(s): T. Zhang, J. Li

      • Abstract

      Loading...

    • +

      JCES01.17 - A Phase I Dose Expansion Study of Epitinib to Evaluate Efficacy and Safety in EGFR Mutation Positive (EGFRm+) NSCLC Patients with Brain Metastasis

      11:10 - 11:10  |  Author(s): Q. Zhou, B. Gan, Q. Hong, M. Wang, X. Liu, L. Yuan, Y. Hua, H. Ren, W. Su, Y.-. Wu

      • Abstract

      Loading...

    • +

      JCES01.18 - Dual Positive PD-L1 and CD8+ TIL Represents a Predominant Subtype in NSCLC and Correlates with Augmented Immunogenicity

      11:10 - 11:10  |  Author(s): S. Liu, Z. Dong, W. Zhong, S. Wu, Z. Xie, H. Tu, Y.-. Wu

      • Abstract

      Loading...

    • +

      JCES01.19 - Clinicopathologic Characteristics, Genetic Variability and Therapeutic Options of RET Rearrangement Patients in Lung Adenocarcinoma

      11:10 - 11:10  |  Author(s): Z. Song, X. Yu, Y. Zhang

      • Abstract

      Loading...

    • +

      JCES01.20 - Patients with ROS1 Rearrangement Positive Non-Small Cell Lung Cancer Benefit from Pemetrexed-Based Chemotherapy

      11:10 - 11:10  |  Author(s): Z. Song, Y. Zhang, X. Yu

      • Abstract

      Loading...

    • +

      JCES01.21 - Molecular Profiling and Survival of Primary Pulmonary Neuroendocrine Carcinoma with Completely Resection

      11:10 - 11:10  |  Author(s): G. Lou, Z. Song, Y. Zhang

      • Abstract

      Loading...

    • +

      JCES01.22 - Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Patients with Non-Small Cell Lung Carcinoma

      11:10 - 11:10  |  Author(s): X. Kang, T. Xu, G. Xu, K. Chen

      • Abstract

      Loading...

    • +

      JCES01.23 - EGFR Mutation Status Analysis in Cerebrospinal Fluid and Plasma of Advanced Lung Adenocarcinoma with Brain Metastases

      11:10 - 11:10  |  Author(s): L. Shi, Z. Liu, J. Tang, H. Wu, L. Guo, M. Li, L. Tong, W. Wu, H. Tao, W. Wu, H. Li, Q. Meng, L. Xu, Y. Zhu

      • Abstract

      Loading...

    • +

      JCES01.24 - Molecular Mechanism of Transformation from Adenocarcinoma to Small-Cell Lung Cancer after EGFR-TKI

      11:10 - 11:10  |  Author(s): J. Han, Q. Zhang, B. Wang, Q. Zhou, L. Yan, Z. Zhang, H. Chen, J. Su, Z. Xie, F. Niu, Y.-. Wu, S. Chuai, J. Yang, Z. Dong

      • Abstract

      Loading...

    • +

      JCES01.25 - Closing Remarks

      11:10 - 11:25

      • Abstract
      • Presentation

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      JCES01.03 - Perspectives on Precision Medicine for Early Stage NSCLC

      11:25 - 11:45  |  Author(s): J. Hu

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    WS03 - IASLC Meets ESTI: Imaging in Lung Cancer Staging and Diagnosis

    • Type: Workshop
    • Track: Radiology/Staging/Screening
    • Presentations: 4
  • +

    WS04 - Mesothelioma Workshop (Ticketed Session)

    • Type: Workshop
    • Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
    • Presentations: 6
    • Coordinates: 12/04/2016, 08:00 - 11:00, Stolz 2
  • +

    YI01a - Clinical Trials & Scientific Mentoring

    • Type: Young Investigator Session
    • Track: WCLC 2016
    • Presentations: 5
  • +

    YI01b - Scientific Mentoring

    • Type: Young Investigator Session
    • Track:
    • Presentations: 5
  • +

    PR01 - Press Conference

    • Type: Press Conference
    • Track:
    • Presentations: 6
    • +

      PR01.01 - Welcome

      10:30 - 10:30  |  Author(s): R. Pirker, G.V. Scagliotti

      • Abstract

      Abstract not provided

    • +

      PR01.02 - Shared Decision Making (SDM) and Patient Decision Aids (PDAs) in Lung Cancer: Survey of Patients, Significant Others or Caregivers

      10:30 - 10:30  |  Author(s): L. Gaspar

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR01.03 - The ALCF Centers of Excellence Model Delivers a Standard of Care to the Community Similar to Academic and Research Centers

      10:30 - 10:30  |  Author(s): R.U. Osarogiagbon

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR01.04 - Mesothelioma Workshop

      10:30 - 10:30  |  Author(s): M. Carbone

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR01.05 - E-health and Future Technologies in Evidence Based Nursing Care

      10:30 - 10:30  |  Author(s): R. Maguire

      • Abstract

      Abstract not provided

    • +

      PR01.06 - Honored Guest

      10:30 - 10:30

      • Abstract

      Abstract not provided

  • +

    ISS01 - Industry Supported Symposium: Current and Emerging Treatments for Patients with ALK+ NSCLC – ARIAD Pharmaceuticals Inc.

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 5
    • +

      ISS01.01 - Welcome & Introduction

      12:00 - 12:05  |  Author(s): C. Zielinski, D..R. Camidge

      • Abstract

      Abstract not provided

    • +

      ISS01.02 - ALK Inhibitors: Current Treatments and Sequencing

      12:05 - 12:30  |  Author(s): C. Zielinski

      • Abstract

      Abstract not provided

    • +

      ISS01.03 - The Future of ALK Inhibitors: How the Treatment Paradigm May Change

      12:30 - 12:55  |  Author(s): D..R. Camidge

      • Abstract

      Abstract not provided

    • +

      ISS01.04 - Will Mutation Testing be Standard in the Resistant Setting?

      12:55 - 13:20  |  Author(s): P. Jänne

      • Abstract

      Abstract not provided

    • +

      ISS01.05 - Summary and Conclusions

      13:20 - 13:30  |  Author(s): C. Zielinski, D..R. Camidge

      • Abstract

      Abstract not provided

  • +

    ISS02 - Industry Supported Symposium: ALK and ROS1 in NSCLC: Optimising the Continuum of Care - Pfizer Oncology

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 8
    • +

      ISS02.01 - Welcome & Introduction

      13:45 - 13:50  |  Author(s): B. Solomon

      • Abstract

      Abstract not provided

    • +

      ISS02.02 - The Importance of Molecular Testing in NSCLC

      13:50 - 14:00  |  Author(s): B. Solomon

      • Abstract

      Abstract not provided

    • +

      ISS02.03 - ALK+ NSCLC: How Can We Maximise Clinical Outcome Today?

      14:00 - 14:20  |  Author(s): N. Girard

      • Abstract

      Abstract not provided

    • +

      ISS02.04 - Clinical Consequences of Resistance to ALK Inhibitors

      14:20 - 14:40  |  Author(s): C. Lovly

      • Abstract

      Abstract not provided

    • +

      ISS02.05 - Panel Discussion

      14:40 - 14:50  |  Author(s): B. Solomon, N. Girard, C. Lovly

      • Abstract

      Abstract not provided

    • +

      ISS02.06 - ROS1+ NSCLC: Clinical Data and Experience

      14:50 - 15:05  |  Author(s): B. Solomon

      • Abstract

      Abstract not provided

    • +

      ISS02.07 - Panel Discussion

      15:05 - 15:10  |  Author(s): B. Solomon, N. Girard, C. Lovly

      • Abstract

      Abstract not provided

    • +

      ISS02.08 - Meeting Close

      15:10 - 15:15  |  Author(s): B. Solomon

      • Abstract

      Abstract not provided

  • +

    ISS03 - Industry Supported Symposium: Non-Small Cell Lung Cancer: The Programmed Death-Ligand 1 (PD-L1) Receptor as a Target for Monotherapy and in Combination – Merck-Pfizer Alliance

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 6
    • +

      ISS03.01 - Welcome and Overview

      15:30 - 15:45  |  Author(s): S. Popat

      • Abstract

      Abstract not provided

    • +

      ISS03.02 - Anti-PD-L1 Monotherapy in Non-Small Cell Lung Cancer (NSCLC): Overview of the Trials Examining anti-PD-L1 Monotherapy in NSCLC

      15:45 - 16:00  |  Author(s): R.A. Juergens

      • Abstract

      Abstract not provided

    • +

      ISS03.03 - Anti-PD-L1 Combined with Other Agents in NSCLC: Combinations with non-Immunooncology Agents

      16:00 - 16:15  |  Author(s): J.E. Gray

      • Abstract

      Abstract not provided

    • +

      ISS03.04 - Anti-PD-L1 Combined with Other Agents in NSCLC: Immuno-Oncology Combinations

      16:15 - 16:30  |  Author(s): S.I. Rothschild

      • Abstract

      Abstract not provided

    • +

      ISS03.05 - Anti-PD-L1 Agents: Opportunities for Differentiation

      16:30 - 16:45  |  Author(s): H. Borghaei

      • Abstract

      Abstract not provided

    • +

      ISS03.06 - Summary, Questions and Close

      16:45 - 17:00  |  Author(s): S. Popat

      • Abstract

      Abstract not provided